Can the FDA keep the momentum going for rare disease drug approvals?
Following a year filled with several approvals for rare disease drugs, experts are expecting this trend to continue in 2023....
23 January, 2023
Clinical Research
Cannabis and cannabis-derived compounds: Quality considerations for clinical research guidance for industry
The FDA recently released guidance related to clinical research on human drugs containing cannabis or cannabis-derived compounds....
23 January, 2023
How one pharma exec uses her father’s cancer experience to better patients’ clinical journeys
Exploring ways clinical trial leaders and organizers can improve the patient experience....
23 January, 2023
Inclusive drugs: designing clinical trials for the pregnant population
Experts share why protection by the exclusion of pregnant people leads to a lack of evidence-based medicine and ways to improve clinical trial conduct....
19 January, 2023
Innovating new T-cell therapies
After completing difficult bouts of chemotherapy, Larson contacted the UW Health | Carbone Cancer Center to see which clinical trials he could explore....
19 January, 2023
Better recognition for research participants: What society should learn from COVID-19
Doing more to acknowledge the important role of clinical trials participants could help with recruitment....
17 January, 2023
The long-term impact of COVID-19 on clinical trials: Part 2
An analysis of the pandemic's impacts on broader organizational and sector level dynamics in clinical research such as competitor collaboration, globalization, industry goodwill, public health, supply chain, and workplace environment....
16 January, 2023
A blood test for cancer shows promise thanks to machine learning
A team of researchers at the University of Wisconsin–Madison has successfully combined genomics with machine learning in the quest to develop accessible tests that allow earlier detection of cancer....
13 January, 2023
Association of Clinical Research Professionals’ response to FDA draft guidance on diversity in clinical trials
Increased diversity in clinical trials should be a requirement, not a suggestion....
12 January, 2023
Harnessing data to foster research and improve public health
The COVID-19 pandemic radically changed our perspectives on how to conduct research and clinical care, and it set the stage for data-driven biomedical research and clinical practice....
12 January, 2023